Increasing the Efficiency of Biosimilar Development Programs (Day 2)

The U.S. Food and Drug Administration (FDA) and the International Pharmaceutical Regulators Program (IPRP) Biosimilars Working Group (BWG) hosted a virtual workshop "Increasing the Efficiency of Biosimilar Development Programs - Reevaluating the Need for Comparative Clinical Efficacy Studies" on September 12-13, 2023. This video shows Day 2 of the public sessions of the workshop.
For more information, visit: www.fda.gov/dr...